— Know what they know.
Not Investment Advice
Also trades as: CYAD (NASDAQ) · $vol 0M · CYAD.BR (BRU) · $vol 0M · 0QFK.L (LSE) · $vol 0M

CLYYF Earnings

Celyad Oncology S.A.
1W: +0.0% 1M: +0.0% 3M: +12.0% YTD: +86.7% 1Y: -31.7% 3Y: -99.4%
$0.28
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 51 · $12.5M mcap · 44M float · 0.0000% daily turnover
Last Earnings 2026-09-23
EPS
€-0.03 (US$-0.03)
▼ Miss +0.0%
Revenue
—

Estimate vs Actual

Earnings Surprise History

4/16
EPS Beats
0/16
Revenue Beats
25%
EPS Beat Rate
0%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-08-11 annual 2021-12-31 €— €-1.54 ▼ 1.54 €— €1,002,872
2026-08-11 annual 2020-12-31 €— €-2.20 ▼ 2.20 €— €1,350,822
2026-08-11 annual 2019-12-31 €— €-2.26 ▼ 2.26 €— €5,931
2026-08-11 annual 2018-12-31 €— €-3.01 ▼ 3.01 €— €2,440,796
2026-08-11 annual 2017-12-31 €— €-3.53 ▼ 3.53 €— €5,314,142
2026-08-11 annual 2016-12-31 €— €-3.36 ▼ 3.36 €— €25,126
2026-04-10 annual 2025-12-31 €-0.32 €-0.32 — €177,794 €20,991
2026-01-12 annual 2025-12-31 €-0.32 €-0.32 — €177,794 €177,794
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms